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Abstract 
The progression of colorectal cancer is commonly characterized by accumulation of genetic or 
epigenetic abnormalities, altering regulation of gene expression as well as normal protein structures 
and functions. Nonetheless, there are some questions that remain to be elucidated, such as the origin 
of cancer cells and populations of cells initiating and propagating tumor development. Currently, 
there are two rival theories describing the process of carcinogenesis. One is the stochastic model, 
arguing that any cell is capable of initiating and triggering the development of cancer. Meanwhile, 
the cancer stem cell model hypothesizes that only a small fraction of stem cells possesses cancer-
promoting properties. Typically, colorectal cancer stem cells (CSCs) share the same molecular 
signaling profiles with normal stem cells or embryonic stem cells, such as Wnt, Notch, TGF-β, and 
Hedgehog. Nevertheless, CSCs differ from normal stem cells and the bulk of tumor cells in their 
tumorigenic potential and susceptibility to chemotherapeutic drugs. This may be a possible 
explanation of the high percentage of cancer recurrence in patients who underwent 
chemotherapeutic treatment and surgery. This review article focuses on the colorectal cancer stem 
cell biomarkers and the role of upregulated signaling pathways implicated in the initiation and 
progression of colorectal cancer. 
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